Producing drugs in outer space – Katie King, BioOrbit

Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works. 

BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions. 

What is UKTN | The Podcast?

Each week, Jane Wakefield sits down with some of the key movers and shakers from the UK tech ecosystem for the UKTN Podcast. Learn growth strategies from both seasoned and up-and-coming founders, hear market sentiments from investors, and understand the tech policy affecting businesses across the country.

The UKTN Podcast provides insight into the most influential people in the UK’s innovation economy, exploring their personal and professional journeys and hearing their views on the hottest tech topics of the day.